Concepedia

Author

Jean Pierre Droz

Institut Gustave Roussy

Also Known As

JEAN PIERRE DROZ, Jean P. Droz, Jean P. Droz, Jean Pierre Droz

52

Publications

1.4K

Citations

16

H-Index

23

Concepts

All Affiliations

Institut Gustave RoussyCentre Léon BérardInstitut National d'OncologieInstitut CurieHôpital Saint-Louis
JP

About

Jean Pierre Droz is an author at Institut Gustave Roussy specializing in medicine, urology, and testicular tumours.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

294

2

Pathology

2

2

141

3

Geriatrics

1

1

71

4

Gerontology

1

1

71

5

Obstetrics

1

1

80

Jean Pierre Droz

×

12

Publications

996

Citations

11

H-Index

YearCitations

Comparison of the 5-Hydroxytryptamine<sub>3</sub>(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis

Michel Marty, P Pouillart, Jean Pierre Droz,

New England Journal of Medicine

1990

411

Open-Label Phase II Study Evaluating the Efficacy and Safety of Two Doses of Pertuzumab in Castrate Chemotherapy-Naive Patients With Hormone-Refractory Prostate Cancer

Johann S. de Bono, Joaquim Bellmunt, Gerhardt Attard,

Journal of Clinical Oncology

2007

131

Prognostic factors in advanced nonseminomatous testicular cancer a multivariate logistic regression analysis

Jean Pierre Droz, Marwane Ghosn, G. Piot,

Cancer

1988

80

Geriatric Assessment in Elderly Patients with Prostate Cancer

C. Terret, G. Albrand, Jean Pierre Droz

Clinical Prostate Cancer

2004

71

Multimodality treatment of patients with liver metastases from germ cell tumors

Michel Rivoire, Dominique Elias, Franco De Cian,

Cancer

2001

70

Primary Mediastinal Germ Cell Tumors

Etienne Lemarié, Pascal Assouline, P. Diot,

CHEST Journal

1992

61

Outcome of recurrent and metastatic small cell carcinoma of the bladder

Nabil Ismaili, Pierre-Étienne Heudel, Fadi Elkarak,

BMC Urology

2009

52

GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting

Michel Marty, Jean Pierre Droz, P Pouillart,

Cancer Chemotherapy and Pharmacology

1989

39

Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Herlinde Dumez, Enrique Gallardo, Stéphane Culine,

Marine Drugs

2009

27

One-stage approach for retroperitoneal and mediastinal metastatic testicular tumor resection

Élie Fadel, B Court, Alain Chapelier,

The Annals of Thoracic Surgery

2000

22

Page 1